Strutt & Parker - Fulham mainly list properties in SW6, W6 and W14. Over the last 6 months, they've listed 29 properties, with 36 currently on the market.
Most of the properties listed
have 4 bedrooms.
They list properties for sale on
both Rightmove and OnTheMarket.
Sophie Alexander was incredibly helpful, proactive and professional during our search for a family house to rent. Whilst we decided to go for a property listed with another agent, my husband and I were very impressed by Sophie and the team, and would highly recommend Strutt & Parker Fulham.
31st May 2017
Both Strutt & Parker Fulham's Sales and Lettings continue to impress. The professional standard of both is very reassuring. One can be sure one is in good hands throughout.
23rd March 2017
We bought our house through S&P and then subsequently rented it (with full property management) through them over the duration of five years. From start to finish, they delivered an exceptional service, particularly on the management side providing us with multiple comparison quotes for works that needed to be carried out, prompt and forewarning on any external / third party deadlines and payments, and total handling of all house-related 'life admin'. I slightly feel like I've lost my very own PA now! During the rental process, we were kept up to date (in real time) on all viewings and feedback and received several offers within weeks of it being on the market. Thank you for everything. If I could have you manage the home I live in, I would!
15th March 2017
I have been using Strutt & Parket Fulham to let my apartment since I left UK 2015. Their team is excellent and has been very helpful. Their follow ups are very thorough too!
I was delighted with the service Strutt and Parker offered in regard to selling my home in Brandy Hole Lane Chichester. The real value of their service became apparent in the very testing weeks between offer and exchange of contracts. I really dont think I would have made it to exchange without their patience and wise council. Thank you to everyone at S&P.